Download Entire Catalog - Regis Technologies
Download Entire Catalog - Regis Technologies
Download Entire Catalog - Regis Technologies
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Regis</strong> <strong>Technologies</strong>, Inc.<br />
Growth and Leadership<br />
<strong>Regis</strong> <strong>Technologies</strong>, Inc. is proud of its<br />
continued growth and leadership role in<br />
its three areas of business: technically<br />
advanced chromatography products, custom<br />
bulk pharmaceuticals and other fine organic<br />
chemicals chromatographic separations.<br />
Expanded Manufacturing Facility<br />
<strong>Regis</strong> management continuously reinvests<br />
in the company. Between 1995 and 2006,<br />
<strong>Regis</strong> expanded and improved every lab and<br />
manufacturing area. This included a new<br />
production facility with six dedicated reactor<br />
Chromatography<br />
<strong>Regis</strong> <strong>Technologies</strong>, Inc. has a long tradition of serving<br />
the analytical needs of scientists and researchers worldwide<br />
with its vast array of chromatography products and<br />
technical assistance. <strong>Regis</strong> manufactures an extensive<br />
line of chromatography stationary phases and high purity<br />
GC derivatization reagents. <strong>Regis</strong> is the exclusive manufacturer of<br />
Pirkle-Type Chiral Stationary Phases for analytical, semi-preparative<br />
and preparative applications and separations. <strong>Regis</strong> is also the<br />
exclusive manufacturer of many other specialty HPLC phases.<br />
Research and development are essential parts of our chromatography<br />
business that allows us to introduce new and innovative products<br />
that meet the needs of our customers.<br />
Custom Synthesis<br />
In addition to chromatography products, <strong>Regis</strong> manufactures Active<br />
Pharmaceutical Ingredients (APIs) and intermediates on a custom<br />
basis. We are committed to meeting our customers’ needs through<br />
initial process development, scale-up and ongoing production. Our<br />
facility is run according to current Good Manufacturing Practices<br />
(cGMP) and is routinely inspected by the FDA. All pharmaceutical<br />
intermediates and final products are manufactured and tested to<br />
customer specifications. All technology developed for the customer<br />
is owned by the customer and all batch records are provided to the<br />
customer as well. In addition to APIs, <strong>Regis</strong> also produces and catalogs<br />
a number of fine organic chemicals. For a complete list, check our Web<br />
site at www.registech.com/portfolio.html.<br />
Preparative Chromatography<br />
<strong>Regis</strong>’ production department includes a pilot plant dedicated to cGMP<br />
chromatography. Glass gravity columns are available in diameters of<br />
4", 6", 9" and 12", with capacities of up to 50 kg of packing material.<br />
suites, individual kilo lab suites, an expanded<br />
quality control department and the installation<br />
of a cryogenic reactor. Plans are underway<br />
for increasing capacity with additional<br />
production labs, individual kilo lab suites<br />
and reactor suites. The net result is loyal<br />
and satisfied customers and employees.<br />
For updates on our expansion, check our<br />
Web site at www.registech.com/gmp.<br />
For more information visit www.registech.com/chiral 3